Cryo-Cell International, Inc. ( CCEL) - Key Metrics
CCEL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.97 | -$0.58 | $0.16 | $0.15 |
| 2025Q3 | $0.97 | $0.20 | $0.31 | $0.31 |
| 2025Q2 | $0.98 | $0.04 | $0.09 | $0.08 |
CCEL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.71 |
| 2025Q3 | ? | 5.84 |
| 2025Q2 | 340.29% | 29.07 |
CCEL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 6.34% | ? |
| 2026Q1 | 2.14% | ? |
| 2025Q4 | 3.78% | ? |
| 2025Q3 | 6.60% | ? |
| 2025Q2 | 1.56% | 2.93% |
CCEL
Price: $3.47
Forward Dividend Yield: 16.35%
Dividend Per Share: 0.60 USD
Earnings Per Share: -0.31 USD
Exchange: ASE
Sector: Healthcare
Industry: Medical Care Facilities
Country: United States
Volume: 6000
Market Capitalization: 27.9 million
Average Dividend Frequency: 4
Years Paying Dividends: 2